335 related articles for article (PubMed ID: 23562535)
1. Carboxymethyl starch and lecithin complex as matrix for targeted drug delivery: I. Monolithic mesalamine forms for colon delivery.
Mihaela Friciu M; Canh Le T; Ispas-Szabo P; Mateescu MA
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):521-30. PubMed ID: 23562535
[TBL] [Abstract][Full Text] [Related]
2. The influence of protonation ratio on properties of carboxymethyl starch excipient at various substitution degrees: Structural insights and drug release kinetics.
Assaad E; Mateescu MA
Int J Pharm; 2010 Jul; 394(1-2):75-84. PubMed ID: 20435114
[TBL] [Abstract][Full Text] [Related]
3. Carboxymethyl Starch Excipients for Drug Chronodelivery.
Ispas-Szabo P; De Koninck P; Calinescu C; Mateescu MA
AAPS PharmSciTech; 2017 Jul; 18(5):1673-1682. PubMed ID: 27686941
[TBL] [Abstract][Full Text] [Related]
4. Development and in vitro evaluation of mesalamine delayed release pellets and tableted reservoir-type pellets.
Bendas ER; Christensen JM; Ayres JW
Drug Dev Ind Pharm; 2010 Apr; 36(4):393-404. PubMed ID: 19740039
[TBL] [Abstract][Full Text] [Related]
5. Two release rates from monolithic carboxymethyl starch tablets: formulation, characterization, and in vitro/in vivo evaluation.
Le TC; Mateescu MA
Drug Deliv Transl Res; 2017 Aug; 7(4):516-528. PubMed ID: 28386870
[TBL] [Abstract][Full Text] [Related]
6. Carboxymethyl starch: Chitosan monolithic matrices containing diamine oxidase and catalase for intestinal delivery.
Calinescu C; Mondovi B; Federico R; Ispas-Szabo P; Mateescu MA
Int J Pharm; 2012 May; 428(1-2):48-56. PubMed ID: 22402476
[TBL] [Abstract][Full Text] [Related]
7. Polyelectrolyte complex of carboxymethyl starch and chitosan as protein carrier: oral administration of ovalbumin.
Assaad E; Blemur L; Lessard M; Mateescu MA
J Biomater Sci Polym Ed; 2012; 23(13):1713-28. PubMed ID: 21967707
[TBL] [Abstract][Full Text] [Related]
8. Pulsatile drug delivery to ileo-colonic segments by structured incorporation of disintegrants in pH-responsive polymer coatings.
Schellekens RC; Stellaard F; Mitrovic D; Stuurman FE; Kosterink JG; Frijlink HW
J Control Release; 2008 Dec; 132(2):91-8. PubMed ID: 18775755
[TBL] [Abstract][Full Text] [Related]
9. [DDS preparations of drugs for inflammatory bowel disease].
Takada K
Nihon Rinsho; 1999 Nov; 57(11):2508-15. PubMed ID: 10572421
[TBL] [Abstract][Full Text] [Related]
10. A novel stimuli-synchronized alloy-treated matrix for space-defined gastrointestinal delivery of mesalamine in the Large White pig model.
Bawa P; Choonara YE; du Toit LC; Kumar P; Ndesendo VM; Meyer LC; Pillay V
J Control Release; 2013 Mar; 166(3):234-45. PubMed ID: 23274950
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and characterization of pH-sensitive hydrogel composed of carboxymethyl chitosan for colon targeted delivery of ornidazole.
Vaghani SS; Patel MM; Satish CS
Carbohydr Res; 2012 Jan; 347(1):76-82. PubMed ID: 22099382
[TBL] [Abstract][Full Text] [Related]
12. Novel self-assembled mesalamine-sucralfate complexes: preparation, characterization, and formulation aspects.
Ispas-Szabo P; Friciu MM; Nguyen P; Dumoulin Y; Mateescu MA
Drug Dev Ind Pharm; 2016; 42(7):1183-93. PubMed ID: 26574144
[TBL] [Abstract][Full Text] [Related]
13. Sustained delivery of intact drug to the colon: mesalamine formulation and temporal gastrointestinal transit analysis.
Chuong MC; Christensen JM; Ayres JW
Pharm Dev Technol; 2009; 14(1):116-25. PubMed ID: 18821272
[TBL] [Abstract][Full Text] [Related]
14. Colon-specific delivery of 5-aminosalicylic acid from chitosan-Ca-alginate microparticles.
Mladenovska K; Raicki RS; Janevik EI; Ristoski T; Pavlova MJ; Kavrakovski Z; Dodov MG; Goracinova K
Int J Pharm; 2007 Sep; 342(1-2):124-36. PubMed ID: 17590293
[TBL] [Abstract][Full Text] [Related]
15. High-amylose sodium carboxymethyl starch matrices for oral, sustained drug-release: formulation aspects and in vitro drug-release evaluation.
Brouillet F; Bataille B; Cartilier L
Int J Pharm; 2008 May; 356(1-2):52-60. PubMed ID: 18280069
[TBL] [Abstract][Full Text] [Related]
16. Novel mesalamine-loaded beads in tablets for delayed release of drug to the colon.
Nguyen C; Christensen JM; Ayres JW
Pharm Dev Technol; 2012; 17(1):73-83. PubMed ID: 20923254
[TBL] [Abstract][Full Text] [Related]
17. Anthocyanins Formulated with Carboxymethyl Starch for Gastric and Intestinal Delivery.
De Sousa Sabino LB; Copes F; Saulais S; De Brito ES; Da Silva Júnior IJ; Le TC; Mateescu MA; Mantovani D
Molecules; 2022 Oct; 27(21):. PubMed ID: 36364096
[TBL] [Abstract][Full Text] [Related]
18. NMR imaging of chitosan and carboxymethyl starch tablets: swelling and hydration of the polyelectrolyte complex.
Wang YJ; Assaad E; Ispas-Szabo P; Mateescu MA; Zhu XX
Int J Pharm; 2011 Oct; 419(1-2):215-21. PubMed ID: 21864660
[TBL] [Abstract][Full Text] [Related]
19. Development and characterization of colon specific drug delivery system bearing 5-ASA and Camylofine dihydrochloride for the treatment of ulcerative colitis.
Dubey R; Dubey R; Omrey P; Vyas SP; Jain SK
J Drug Target; 2010 Sep; 18(8):589-601. PubMed ID: 20088681
[TBL] [Abstract][Full Text] [Related]
20. Enzymatically degraded Eurylon 6 HP-PG: ethylcellulose film coatings for colon targeting in inflammatory bowel disease patients.
Karrout Y; Neut C; Siepmann F; Wils D; Ravaux P; Deremaux L; Flament MP; Dubreuil L; Lemdani M; Desreumaux P; Siepmann J
J Pharm Pharmacol; 2010 Dec; 62(12):1676-84. PubMed ID: 21054393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
